Association between Sleep, Alzheimer’s, and Parkinson’s Disease
The majority of neurodegenerative diseases are pathologically associated with protein misfolding and aggregation. Alzheimer’s disease (AD) is a type of dementia that slowly affects memory and cognitive function, and is characterized by the aggregation of the β-amyloid protein and tau neurofibrillary...
Enregistré dans:
Auteurs principaux: | Sumire Matsumoto, Tomomi Tsunematsu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d527a4a5904e4e9784cae55e7bc4a2e5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
par: Guo YJ, et autres
Publié: (2016) -
Liposome delivery systems for the treatment of Alzheimer’s disease
par: Ross C, et autres
Publié: (2018) -
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
par: Vyronia Vassilakopoulou, et autres
Publié: (2021) -
Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
par: Javdani N, et autres
Publié: (2019) -
Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
par: Alimohammadi E, et autres
Publié: (2020)